Paediatric medicines

Paediatric medicines

While most of PENTA’s activities involve paediatric medicines, the projects under this heading are those that focus specifically on building capacity for the development and marketing of paediatric formulations or medicines or address identified gaps or urgent needs in the development of drugs for children.

Our objective is to facilitate the generation of information needed to ensure that the right drugs at the right doses are available for use by children and newborns.